Search results
Sen. Sanders calls for Novo Nordisk subpoena over Wegovy and Ozempic pricing
BenefitsPRO· 3 days agoMembers of the Senate HELP Committee will vote June 18 on whether to subpoena Doug Langa, the...
Blue Cross Blue Shield of Michigan dropping coverage of weight loss drugs
CBS News· 2 days agoMichigan's largest insurance company said it will begin eliminating coverage of various weight loss...
Poop has been an easy target for microbiome research, but voyages into the small intestine shed new...
The Conversation via Yahoo News· 1 day agoSome small intestine metabolites help regulate the upper gut’s production of GIP, a sister molecule...
US Senate panel to weigh Novo Nordisk subpoena over Ozempic, Wegovy prices
AOL· 4 days ago-The U.S. Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S. prices for weight loss drugs Ozempic and Wegovy ...
Supplements for weight loss: What are they and how do they work
The Telegraph via Yahoo News· 1 day agoIf your weight is posing a serious risk to your overall health, your doctor may prescribe the new...
Focus: Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters· 5 days ago, opens new tab Zepbound can cut heart disease risk, treat sleep apnea and address other health...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 2 days agoAffordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy
IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
Investor's Business Daily· 18 hours agoNovo Nordisk stock initially broke out on June 4 in heavier-than-average volume. On May 2, the...
Novo Nordisk CEO to Testify in US Senate Hearing on High Cost of Ozempic, Wegovy
US News & World Report· 16 hours agoA U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to subpoena Novo to answer questions about U.S. prices for the blockbuster drugs, is no longer necessary ...
3 Stocks to Sell as Ozempic Surges in Popularity
InvestorPlace· 1 day agoNovo Nordisk’s (NYSE:NVO) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest...